Archive > Volume 28 Issue 4 > 2021,28(4):392-397. DOI:10.3872/j.issn.1007-385X.2021.04.012 Prev Next

Review

Advances and challenges of chimeric antigen receptor gene modified-T lymphocyte therapy for lung cancer

您是第位访问者
Chinese Journal Of Cancer Biotheray ® 2025 All Rights Reserved
Supported by:Beijing E-Tiller Technology Development Co., Ltd.